Spesolimab for preventing generalised pustular psoriasis flares [ID6216]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Apremilast for treating moderate to severe plaque psoriasis in people aged 6 to 17 TS ID 11921Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasisStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Secukinumab biosimilar for treating plaque psoriasis TSID 11992Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years TSID 12002Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC